Kanna Hayashi Selected Research

Pain (Aches)

3/2024	Denial of prescription pain medication among people who use drugs in Vancouver, Canada.
1/2023	Cannabis use to manage opioid cravings among people who use unregulated opioids during a drug toxicity crisis.
1/2021	The effect of depressive symptoms on pain in a substance-using population with persistent pain: a cross-sectional cohort study.
11/2020	Withdrawal-associated injury site pain prevalence and correlates among opioid-using people who inject drugs in Vancouver, Canada.
1/2020	Characterizing motivations for cannabis use in a cohort of people who use illicit drugs: A latent class analysis.
1/2016	Seeking prescription opioids from physicians for nonmedical use among people who inject drugs in a Canadian setting.
9/2015	Pain Among High-Risk Patients on Methadone Maintenance Treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kanna Hayashi Research Topics

Disease

23	Opioid-Related Disorders (Opiate Addiction) 01/2023 - 07/2015
19	Substance-Related Disorders (Drug Abuse) 10/2023 - 01/2016
10	HIV Seropositivity 10/2023 - 03/2014
10	HIV Infections (HIV Infection) 12/2019 - 05/2011
8	Opiate Overdose 12/2021 - 01/2018
7	Pain (Aches) 03/2024 - 09/2015
6	COVID-19 01/2024 - 01/2022
6	Hepatitis C 01/2023 - 01/2016
4	Chronic Pain 01/2023 - 09/2015
2	Drug-Related Side Effects and Adverse Reactions 01/2023 - 01/2023
2	Drug Overdose 01/2020 - 10/2019
2	Soft Tissue Infections 01/2019 - 09/2013
2	Infections 01/2019 - 09/2017
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 03/2016
1	Frailty 01/2023
1	Poisoning 12/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 05/2020
1	Nausea 01/2020
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020
1	Major Depressive Disorder (Major Depressive Disorders) 01/2018
1	Alcoholism (Alcohol Abuse) 01/2018
1	Mental Disorders (Mental Disorder) 09/2015
1	Marijuana Use 09/2015
1	Vascular System Injuries 05/2013

Drug/Important Bio-Agent (IBA)

35	Opioid Analgesics (Opioids)IBA 03/2024 - 09/2015
18	Methadone (Dolophine)FDA LinkGeneric 06/2023 - 07/2015
12	Illicit Drugs (Recreational Drugs)IBA 01/2023 - 09/2015
10	Fentanyl (Sublimaze)FDA LinkGeneric 10/2023 - 01/2018
9	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2023 - 09/2015
8	Heroin (Diamorphine)IBA 03/2024 - 09/2013
6	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2023 - 05/2011
3	COVID-19 VaccinesIBA 01/2024 - 10/2023
3	Naloxone Drug Combination Buprenorphine FDA Link 06/2023 - 01/2022
3	Cocaine (Cocaine HCl)IBA 11/2019 - 11/2014
3	BenzodiazepinesIBA 05/2016 - 10/2015
2	Therapeutic UsesIBA 01/2023 - 01/2020
2	Antiviral Agents (Antivirals)IBA 01/2019 - 01/2017
1	VaccinesIBA 10/2023
1	Morphine (MS Contin)FDA LinkGeneric 01/2023
1	N-nitrosoiminodiacetic acidIBA 12/2022
1	Oxycodone (Oxycontin)FDA LinkGeneric 11/2022
1	Hallucinogens (Psychedelics)IBA 01/2022
1	InterferonsIBA 01/2019
1	Reverse Transcriptase InhibitorsIBA 09/2017
1	tryptamineIBA 01/2017
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2017
1	Prescription DrugsIBA 10/2015
1	Analgesics (Analgesic Drugs)IBA 09/2015
1	Midazolam (Versed)FDA LinkGeneric 05/2013

Therapy/Procedure

23	Therapeutics 03/2024 - 01/2015
1	Time-to-Treatment 01/2023
1	Dental Care 11/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Pain Management 01/2020
1	Aftercare (After-Treatment) 01/2020
1	Condoms (Condom) 12/2019
1	Injections 01/2019
1	Opiate Substitution Treatment 03/2016
1	Art Therapy 03/2016